Cognition Disorders Completed Phase 2 Trials for Armodafinil (DB06413)

IndicationStatusPhase
DBCOND0027877 (Cognition Disorders)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01032200Armodafinil in Treating Fatigue Caused By Radiation Therapy in Patients With Primary Brain TumorsSupportive Care